The Patent Finder

Trega Biosciences, Inc.

Also on record
Records under this name other than patents Trega Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Trega Biosciences, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,350,430Melanocortin receptor ligands and methods of using same
Formerly held
Lapsed on the fee record
Ended Feb 26, 2014 · USPTO record
Lapsed on the fee recordEnded Feb 26, 2014USPTO record
US 6,284,735HP-3228 and related peptides to treat sexual dysfunction
Formerly held
Lapsed on the fee record
Ended Sep 4, 2013 · USPTO record
Lapsed on the fee recordEnded Sep 4, 2013USPTO record
US 6,262,2694-Substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries
Formerly held
Lapsed on the fee record
Ended Jul 17, 2013 · USPTO record
Lapsed on the fee recordEnded Jul 17, 2013USPTO record
US 6,219,537Apparatus and method for an enhanced PCS communication system
Formerly held
Lapsed on the fee record
Ended Apr 17, 2013 · USPTO record
Lapsed on the fee recordEnded Apr 17, 2013USPTO record
US 6,127,381Isoquinoline compound melanocortin receptor ligands and methods of using same
Formerly held
Lapsed on the fee record
Ended Oct 3, 2012 · USPTO record
Lapsed on the fee recordEnded Oct 3, 2012USPTO record
US 6,121,054Method for separation of liquid and solid phases for solid phase organic syntheses
Formerly held
Lapsed on the fee record
Ended Sep 19, 2012 · USPTO record
Lapsed on the fee recordEnded Sep 19, 2012USPTO record
US 6,121,489Selectively N-alkylated peptidomimetic combinatorial libraries and compounds therein
Formerly held
Lapsed on the fee record
Ended Sep 19, 2012 · USPTO record
Lapsed on the fee recordEnded Sep 19, 2012USPTO record
US 6,608,082Treatment of erectile dysfunction using isoquinoline compound melanocortin receptor ligands
Formerly held
Lapsed on the fee record
Ended Aug 19, 2011 · USPTO record
Lapsed on the fee recordEnded Aug 19, 2011USPTO record
US 6,534,503Melanocortin receptor-3 ligands to treat sexual dysfunction
Formerly held
Lapsed on the fee record
Ended Mar 18, 2011 · USPTO record
Lapsed on the fee recordEnded Mar 18, 2011USPTO record
US 6,417,195Isoquinoline derivatives and isoquinoline combinatorial libraries
Formerly held
Lapsed on the fee record
Ended Jul 9, 2010 · USPTO record
Lapsed on the fee recordEnded Jul 9, 2010USPTO record
10 of 52 patents shown.
Pro members see all 52.
Pro members: see all 52 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited